Mettler-Toledo ROE 2012-2025 | MTD
Current and historical return on equity (ROE) values for Mettler-Toledo (MTD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Mettler-Toledo ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.84B | $-0.25B | -408.81% |
| 2025-06-30 | $0.83B | $-0.26B | -459.83% |
| 2025-03-31 | $0.85B | $-0.18B | -551.95% |
| 2024-12-31 | $0.86B | $-0.13B | -582.80% |
| 2024-09-30 | $0.80B | $-0.15B | -517.53% |
| 2024-06-30 | $0.79B | $-0.15B | -554.23% |
| 2024-03-31 | $0.78B | $-0.16B | -617.03% |
| 2023-12-31 | $0.79B | $-0.15B | -852.97% |
| 2023-09-30 | $0.87B | $-0.11B | -1784.62% |
| 2023-06-30 | $0.89B | $-0.09B | -2067.44% |
| 2023-03-31 | $0.89B | $-0.02B | -4730.67% |
| 2022-12-31 | $0.87B | $0.03B | 10270.59% |
| 2022-09-30 | $0.84B | $-0.08B | 1862.22% |
| 2022-06-30 | $0.82B | $0.01B | 778.20% |
| 2022-03-31 | $0.79B | $0.09B | 524.09% |
| 2021-12-31 | $0.77B | $0.17B | 425.41% |
| 2021-09-30 | $0.76B | $0.16B | 361.24% |
| 2021-06-30 | $0.71B | $0.19B | 254.64% |
| 2021-03-31 | $0.66B | $0.20B | 189.99% |
| 2020-12-31 | $0.60B | $0.28B | 162.75% |
| 2020-09-30 | $0.58B | $0.44B | 143.21% |
| 2020-06-30 | $0.55B | $0.45B | 135.48% |
| 2020-03-31 | $0.55B | $0.31B | 131.10% |
| 2019-12-31 | $0.56B | $0.42B | 116.57% |
| 2019-09-30 | $0.55B | $0.44B | 104.87% |
| 2019-06-30 | $0.55B | $0.50B | 100.00% |
| 2019-03-31 | $0.53B | $0.56B | 95.85% |
| 2018-12-31 | $0.51B | $0.59B | 92.46% |
| 2018-09-30 | $0.41B | $0.53B | 75.14% |
| 2018-06-30 | $0.39B | $0.53B | 71.71% |
| 2018-03-31 | $0.38B | $0.56B | 72.40% |
| 2017-12-31 | $0.38B | $0.55B | 76.66% |
| 2017-09-30 | $0.44B | $0.51B | 94.49% |
| 2017-06-30 | $0.43B | $0.46B | 94.23% |
| 2017-03-31 | $0.41B | $0.44B | 88.01% |
| 2016-12-31 | $0.39B | $0.44B | 78.13% |
| 2016-09-30 | $0.37B | $0.50B | 69.94% |
| 2016-06-30 | $0.36B | $0.49B | 65.06% |
| 2016-03-31 | $0.36B | $0.54B | 60.26% |
| 2015-12-31 | $0.35B | $0.58B | 56.80% |
| 2015-09-30 | $0.35B | $0.59B | 53.47% |
| 2015-06-30 | $0.35B | $0.65B | 48.04% |
| 2015-03-31 | $0.34B | $0.67B | 43.65% |
| 2014-12-31 | $0.34B | $0.72B | 39.75% |
| 2014-09-30 | $0.33B | $0.85B | 36.17% |
| 2014-06-30 | $0.32B | $0.91B | 34.97% |
| 2014-03-31 | $0.31B | $0.92B | 35.36% |
| 2013-12-31 | $0.31B | $0.94B | 36.06% |
| 2013-09-30 | $0.30B | $0.85B | 36.64% |
| 2013-06-30 | $0.30B | $0.81B | 36.96% |
| 2013-03-31 | $0.29B | $0.80B | 36.50% |
| 2012-12-31 | $0.29B | $0.83B | 36.30% |
| 2012-09-30 | $0.28B | $0.80B | 35.43% |
| 2012-06-30 | $0.28B | $0.78B | 34.70% |
| 2012-03-31 | $0.27B | $0.81B | 33.78% |
| 2011-12-31 | $0.27B | $0.78B | 33.34% |
| 2011-09-30 | $0.26B | $0.82B | 31.82% |
| 2011-06-30 | $0.25B | $0.84B | 31.70% |
| 2011-03-31 | $0.24B | $0.79B | 31.77% |
| 2010-12-31 | $0.23B | $0.77B | 31.38% |
| 2010-09-30 | $0.22B | $0.76B | 30.39% |
| 2010-06-30 | $0.20B | $0.72B | 28.66% |
| 2010-03-31 | $0.18B | $0.71B | 26.57% |
| 2009-12-31 | $0.17B | $0.71B | 27.97% |
| 2009-09-30 | $0.17B | $0.65B | 29.48% |
| 2009-06-30 | $0.18B | $0.59B | 33.49% |
| 2009-03-31 | $0.20B | $0.52B | 38.20% |
| 2008-12-31 | $0.20B | $0.50B | 38.27% |
| 2008-09-30 | $0.20B | $0.51B | 36.91% |
| 2008-06-30 | $0.19B | $0.55B | 34.91% |
| 2008-03-31 | $0.19B | $0.56B | 32.92% |
| 2007-12-31 | $0.18B | $0.58B | 30.94% |
| 2007-09-30 | $0.17B | $0.53B | 28.41% |
| 2007-06-30 | $0.17B | $0.59B | 27.83% |
| 2007-03-31 | $0.16B | $0.60B | 26.36% |
| 2006-12-31 | $0.16B | $0.63B | 25.04% |
| 2006-09-30 | $0.15B | $0.63B | 23.51% |
| 2006-06-30 | $0.13B | $0.63B | 19.97% |
| 2006-03-31 | $0.11B | $0.64B | 17.18% |
| 2005-12-31 | $0.11B | $0.66B | 16.32% |
| 2005-09-30 | $0.10B | $0.66B | 14.78% |
| 2005-06-30 | $0.10B | $0.66B | 14.55% |
| 2005-03-31 | $0.11B | $0.70B | 15.82% |
| 2004-12-31 | $0.11B | $0.72B | 15.80% |
| 2004-09-30 | $0.11B | $0.67B | 15.74% |
| 2004-06-30 | $0.10B | $0.69B | 16.17% |
| 2004-03-31 | $0.10B | $0.65B | 16.73% |
| 2003-12-31 | $0.10B | $0.65B | 16.68% |
| 2003-09-30 | $0.09B | $0.58B | 17.49% |
| 2003-06-30 | $0.09B | $0.55B | 18.17% |
| 2003-03-31 | $0.09B | $0.52B | 19.34% |
| 2002-12-31 | $0.10B | $0.50B | 21.80% |
| 2002-09-30 | $0.10B | $0.48B | 23.24% |
| 2002-06-30 | $0.10B | $0.45B | 26.25% |
| 2002-03-31 | $0.08B | $0.41B | 25.06% |
| 2001-12-31 | $0.07B | $0.39B | 28.37% |
| 2001-09-30 | $0.06B | $0.23B | 31.76% |
| 2001-06-30 | $0.06B | $0.20B | 33.89% |
| 2001-03-31 | $0.07B | $0.19B | 44.24% |
| 2000-12-31 | $0.07B | $0.18B | 48.70% |
| 2000-09-30 | $0.06B | $0.15B | 47.24% |
| 2000-06-30 | $0.06B | $0.13B | 49.89% |
| 2000-03-31 | $0.05B | $0.12B | 51.49% |
| 1999-12-31 | $0.05B | $0.11B | 54.70% |
| 1999-09-30 | $0.05B | $0.10B | 70.99% |
| 1999-06-30 | $0.04B | $0.08B | 68.05% |
| 1999-03-31 | $0.04B | $0.06B | 75.00% |
| 1998-12-31 | $0.04B | $0.05B | 85.39% |
| 1998-09-30 | $-0.01B | $0.04B | -21.48% |
| 1998-06-30 | $-0.01B | $0.05B | -41.51% |
| 1998-03-31 | $-0.06B | $0.03B | -991.30% |
| 1997-12-31 | $-0.07B | $0.03B | 2363.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.339B | $3.872B |
| Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.511B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $210.153B | 82.22 |
| IDEXX Laboratories (IDXX) | United States | $56.962B | 56.57 |
| Edwards Lifesciences (EW) | United States | $49.401B | 33.12 |
| IQVIA Holdings (IQV) | United States | $41.282B | 23.02 |
| Alcon (ALC) | Switzerland | $39.524B | 26.71 |
| DexCom (DXCM) | United States | $26.287B | 36.24 |
| STERIS (STE) | Ireland | $25.206B | 26.02 |
| Waters (WAT) | United States | $23.626B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.855B | 33.88 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.750B | 0.00 |
| Globus Medical (GMED) | United States | $12.644B | 26.54 |
| Penumbra (PEN) | United States | $12.627B | 88.83 |
| Masimo (MASI) | United States | $7.462B | 23.91 |
| Glaukos (GKOS) | United States | $6.486B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.358B | 20.20 |
| Teleflex (TFX) | United States | $4.986B | 7.94 |
| TransMedics (TMDX) | United States | $4.684B | 55.49 |
| LivaNova (LIVN) | United Kingdom | $3.517B | 19.00 |
| Alphatec Holdings (ATEC) | United States | $3.365B | 0.00 |
| Veracyte (VCYT) | United States | $3.323B | 37.87 |
| Integer Holdings (ITGR) | United States | $2.954B | 13.87 |
| Elekta AB (EKTAY) | Sweden | $2.377B | 22.24 |
| Artivion (AORT) | United States | $2.101B | 96.41 |
| UFP Technologies (UFPT) | United States | $1.986B | 26.22 |
| Nihon Kohden (NHNKY) | Japan | $1.934B | 16.88 |
| PROCEPT BioRobotics (PRCT) | United States | $1.834B | 0.00 |
| AxoGen (AXGN) | United States | $1.546B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.471B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 59.97 |
| Integra LifeSciences Holdings (IART) | United States | $1.058B | 5.73 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.982B | 0.00 |
| SiBone (SIBN) | United States | $0.887B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.887B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.675B | 39.27 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.625B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.588B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.459B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.448B | 12.38 |
| ClearPoint Neuro (CLPT) | United States | $0.424B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.296B | 2.21 |
| CVRx (CVRX) | United States | $0.213B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.162B | 0.00 |
| Neuronetics (STIM) | United States | $0.142B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.141B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Solana (HSDT) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.09 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |